The Safety and Tolerability of SOF/VEL/VOX for 8 or 12 Weeks in >1000 Patients Treated in the POLARIS-1, POLARIS-2, POLARIS-3, and POLARIS-4 Studies: an Integrated Analysis

Press/Media: Press / Media

PeriodApr 27 2017

Media coverage

2

Media coverage

  • TitleThe Safety and Tolerability of SOF/VEL/VOX for 8 or 12 Weeks in >1000 Patients Treated in the POLARIS-1, POLARIS-2, POLARIS-3, and POLARIS-4 Studies: an Integrated Analysis
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date4/27/17
    PersonsEric J Lawitz
  • TitleThe Safety and Tolerability of SOF/VEL/VOX for 8 or 12 Weeks in >1000 Patients Treated in the POLARIS-1, POLARIS-2, POLARIS-3, and POLARIS-4 Studies: an Integrated Analysi
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date4/27/17
    PersonsEric J Lawitz